Clinical Trials Logo

Clinical Trial Summary

The primary purpose of this study is to describe renal anemia treatment patterns in non-dialysis dependent (ND) and dialysis dependent (DD) populations, with a particular focus on iron use in erythropoiesis stimulating agent (ESA) treated patients.

This study will also provide an epidemiological description of chronic kidney disease (CKD) associated anemia in relation to CKD stage, dialysis modality and underlying morbidity, as well as describe the relationship between inflammation and ESA treatment and describe the associated cardiovascular illness in ESA treated patients.


Clinical Trial Description

Data from year 2015 will be used for the prevalence analysis.The prevalent population of CKD patients > 18 years in the Swedish Renal Registry in 2015 both dependent on dialysis (DD) and not on dialysis (ND). ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03643601
Study type Observational
Source Astellas Pharma Inc
Contact
Status Completed
Phase
Start date September 24, 2018
Completion date December 4, 2018